Amprius Technologies

Amprius Technologies

Amprius Technologies was founded in 2008 by Dr. Kang Sun, based on licensed technology from Stanford University, where researcher Yi Cui pioneered the silicon nanowire anode. This origin anchors the firm in fundamental materials science rather than incremental improvement. The company went public via a SPAC merger with Kensington Capital Acquisition Corp. IV in September 2022, trading on the New York Stock Exchange under the ticker AMPX (per the firm's SEC filings, 2022). Its core product is a lithium-ion battery cell that substitutes conventional graphite anodes with a densely packed forest of silicon nanowires, enabling dramatic energy density gains. The firm's primary focus is on high-value, weight-constrained applications. Its batteries target the electric aviation market, with confirmed supply agreements and development partnerships with Airbus and BAE Systems (per Airbus press releases, 2024). Beyond aviation, Amprius addresses other segments of the electrification economy including defense unmanned aerial vehicles and premium electric vehicles. The company does not compete for mass-market passenger EV contracts; its manufacturing cost structure and cell performance are tailored for applications where payload is the binding constraint. The Fremont facility provides a demonstration-scale production line, while a planned gigawatt-hour-scale factory in Brighton, Colorado, is intended to unlock orders from additional commercial customers (per the firm's public announcements). Led by Kang Sun as President and CEO, Amprius operates with a lean corporate structure typical of a pre-profitability industrial technology company. As of early 2025, the company had not yet released a total workforce figure, but SEC filings indicate a mix of R&D engineers and production technicians based in California. The adjacent philanthropic vehicle is the Stanford ecosystem from which the company emerged, though no separate private foundation associated with the firm has been publicly disclosed. The company is an operating business, not a family office or fund — its capital structure relies on public equity and strategic balance-sheet investment rather than third-party managed assets. October 2024: Amprius secured a $20 million purchase order to supply its high-energy cells for light electric-vehicle applications across Asia and the Americas (per the company, October 2024). Amprius sits at the intersection of a public commercial entity and a deep-tech licensing platform. It controls foundational intellectual property in silicon anode design and manufacturing, which distinguishes it from lithium-ion incumbents that must negotiate the trade-off between energy density and cycle life. The company's structural differentiator is this core scientific moat paired with the regulatory imperative facing aerospace and defense contractors — nobody flies a commercial electric aircraft on standard 250 Wh/kg cells. That physics problem creates a narrow, defensible demand corridor that Amprius is built to serve.